KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Total Liabilities (2016 - 2025)

Gilead Sciences (GILD) has disclosed Total Liabilities for 17 consecutive years, with $36.3 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Liabilities fell 8.63% year-over-year to $36.3 billion, compared with a TTM value of $36.3 billion through Dec 2025, down 8.63%, and an annual FY2025 reading of $36.3 billion, down 8.63% over the prior year.
  • Total Liabilities was $36.3 billion for Q4 2025 at Gilead Sciences, up from -$19.6 billion in the prior quarter.
  • Across five years, Total Liabilities topped out at $48.5 billion in Q1 2021 and bottomed at -$19.9 billion in Q1 2022.
  • Average Total Liabilities over 5 years is $29.0 billion, with a median of $40.1 billion recorded in 2023.
  • The sharpest move saw Total Liabilities skyrocketed 305.56% in 2023, then tumbled 155.37% in 2025.
  • Year by year, Total Liabilities stood at $46.9 billion in 2021, then dropped by 10.51% to $42.0 billion in 2022, then dropped by 6.16% to $39.4 billion in 2023, then grew by 0.95% to $39.7 billion in 2024, then fell by 8.63% to $36.3 billion in 2025.
  • Business Quant data shows Total Liabilities for GILD at $36.3 billion in Q4 2025, -$19.6 billion in Q2 2025, and -$19.1 billion in Q1 2025.